News & Updates
Filter by Specialty:
Is night-time better than morning dosing of antihypertensives?
22 Jan 2024
Bedtime dosing of antihypertensive medication is neither better nor worse than morning dosing when it comes to the subsequent risk of all-cause or cardiovascular mortality, according to a study.
Is night-time better than morning dosing of antihypertensives?
22 Jan 2024Capivasertib fits the bill for HR+, HER2– ABC
22 Jan 2024
byElvira Manzano
Capivasertib, when added to fulvestrant, prolonged progression-free survival (PFS) by 4.1 months in an analysis of Chinese patients with hormone receptor–positive (HR+), HER2-negative (HER2– ABC) advanced breast cancer (ABC) whose disease had progressed on aromatase inhibitor, with or without a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor in the phase III CAPItello-291 trial.